Recombinant interferons β and γ have a higher antiviral activity than interferon-α in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts

Journal of Interferon and Cytokine Research

Volumn 16, Issue 4, 1996, Pages 283-287

  Heim, Albert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; FIBROBLAST CULTURE; HEART DISEASE; HEART MUSCLE; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS CARRIER;

EID: 0029881633     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.283     Document Type: Article

References (4)

1. KANDOLF, R., and HOFSCHNEIDER, P.H. (1989). Viral heart disease. Springer Semin. Immunopathol. 11, 1-13.
2. KLINGEL, K., HOHENADL, C, CANU, A., ALBRECHT, M., SEEMANN, M., MALL, G., and KANDOLF, R. (1992). Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89, 314-318.
3. MUIR, P. (1993). Enteroviruses and heart disease. Br. J. Biomed. Sci. 50, 258-271.
4. LIU, P., WANG, E.E.L., and SOLE, M. (1993). Viral myocarditis: changing concepts in pathogenesis and implications in diagnosis and treatment. Cardiovasc. Pathol. 2, 247-257.